2-hydroxyatorvastatin

Known as: 2-hydroxy-atorvastatin, ortho-hydroxyatorvastatin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The pharmacokinetics of statins show substantial inter-subject variability. Increasing systemic exposure of statins may lead to… (More)
Is this relevant?
2015
2015
BACKGROUND AND OBJECTIVE Icosapent ethyl is a high-purity prescription form of eicosapentaenoic acid ethyl ester approved as an… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2014
2014
The present study aimed to evaluate the impact of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in the Chinese Han… (More)
Is this relevant?
2011
2011
Coadministration of statins and fibrates is beneficial in some patients by allowing simultaneous reduction of triglycerides and… (More)
Is this relevant?
2010
2010
OBJECTIVE This study aimed to evaluate the effect of genetic polymorphisms of SLCO1B1 and ABCB1 on the pharmacokinetics of… (More)
Is this relevant?
2010
2010
The aim of the present study was to develop a chromatographic method for the analysis of atorvastatin, Orthoand Para… (More)
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2008
2008
BACKGROUND Prescription omega-3-acid ethyl esters (P-OM3) have been used as adjunctive therapy to statin drugs in patients with… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Thirty-two healthy volunteers with different SLCO1B1 genotypes ingested a 20 mg dose of atorvastatin and 10 mg dose of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2006
2006
Background: The most serious side effect from statin treatment is myopathy, which may proceed to rhabdomyolysis. This is the… (More)
  • figure 1
  • table II
Is this relevant?